• ATRA Overcomes Cisplatin-Induced PARP Inhibitor Resistance i

  2026-06-15

  This study uncovers how all-trans retinoic acid (ATRA) reverses cisplatin-induced resistance to PARP inhibition in epithelial ovarian cancer (EOC). By targeting metabolic and gene expression changes associated with resistance, ATRA enhances the efficacy of PARP inhibitors—offering a promising new maintenance strategy for platinum-experienced EOC patients.

• MMP7-Driven EMT via E-cadherin/β-Catenin Fuels Liver Fibrosi

  2026-06-15

  This study elucidates how matrix metalloproteinase 7 (MMP7) drives liver fibrosis in biliary atresia by inducing epithelial–mesenchymal transition (EMT) through E-cadherin cleavage and β-catenin signaling. The findings establish a mechanistic link between MMP7 activity and fibrogenic progression, offering new insights for targeted therapeutic strategies in pediatric liver disease.

• Meropenem Trihydrate in Modern Resistance Phenotyping Resear

  2026-06-14

  Explore how Meropenem trihydrate unlocks next-generation resistance phenotyping and metabolomics-based diagnostics. This article delves into its advanced scientific applications, bridging molecular insights with experimental workflows.

• ICG001: Wnt/β-Catenin Pathway Inhibitor in Fibrosis Models

  2026-06-13

  ICG001 enables precise dissection of Wnt/β-catenin signaling, offering selective pathway modulation for fibrosis and cancer research. Its CBP-specific inhibition profile supports high-fidelity mechanistic studies and robust translational workflows.

• Sisomicin: Protocols and Troubleshooting in Antibacterial Re

  2026-06-12

  Sisomicin stands out as a potent aminoglycoside antibiotic for rigorous in vitro and in vivo studies, offering distinct advantages for Gram-negative and Gram-positive infection models. This article translates current evidence and reference innovations into actionable protocols, troubleshooting, and comparative insights for researchers seeking robust, reproducible results.

• Triazole ALDH2 Activators: A New Frontier for Myocardial Isc

  2026-06-12

  This article reviews the design and evaluation of novel triazole-based small molecule activators of aldehyde dehydrogenase 2 (ALDH2) for myocardial ischemia therapy. These compounds, with markedly enhanced water solubility and unprecedented activation potency, address longstanding challenges in targeting ischemia-reperfusion injury, offering a basis for future translational research.

• ICG001: Precision Wnt/β-Catenin Inhibition for Advanced Dise

  2026-06-11

  Explore ICG001, a potent Wnt/β-catenin pathway inhibitor, and discover its unique selectivity for CBP/β-catenin interactions in cancer, fibrosis, and regenerative research. This article delivers new insights into targeted assay design and translational applications.

• Protease Inhibitor Cocktail: EDTA-Free Strategies for Protei

  2026-06-11

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO revolutionizes protein extraction in high-stakes applications such as OXPHOS-targeted cancer research and kinase assays. Its EDTA-free, broad-spectrum formulation offers unmatched compatibility and reproducibility, ensuring maximal protein integrity where it matters most.

• HSBP7 Loss Restores Function in Titin Cardiomyopathy Models

  2026-06-10

  Chopra et al. introduce CARDIO, a high-content imaging assay, to systematically profile morphological and functional alterations in human cardiomyocytes derived from induced pluripotent stem cells (iPS-CMs). Their study identifies HSPB7 loss as a novel modifier that reverses contractile dysfunction in titin-deficient dilated cardiomyopathy, offering new mechanistic insights for heart failure research.

• MMP7 Drives EMT and Liver Fibrosis via E-cadherin/β-Catenin

  2026-06-10

  This study elucidates how matrix metalloproteinase 7 (MMP7) promotes liver fibrosis in biliary atresia by inducing epithelial–mesenchymal transition (EMT) through E-cadherin cleavage and β-catenin signaling. The findings pinpoint MMP7 as a mechanistic driver of fibrosis and a promising therapeutic target, advancing understanding of fibrogenic pathways in pediatric liver disease.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-06-09

  Anlotinib hydrochloride empowers cancer research by enabling highly selective, quantitative inhibition of angiogenesis and tumor proliferation pathways. Its unique multi-target kinetic profile, robust pharmacodynamics, and superior in vitro safety position it as a next-generation standard for endothelial migration and tube formation assays.

• Luminescent ATP Detection Assay Kit: Precision in Cellular A

  2026-06-09

  The Luminescent ATP Detection Assay Kit leverages robust firefly luciferase chemistry to deliver highly sensitive, reproducible ATP quantification across cells and tissues. Its streamlined protocol and compatibility with downstream applications set a new standard for energy metabolism and inflammation research.

• Gly-Gly-Phe-Gly: Advancing Bioconjugation and ADC Precision

  2026-06-08

  Harnessing the flexible linker properties of the GGFG peptide, researchers can streamline drug conjugation and antibody-drug conjugate workflows with unmatched reproducibility. This guide details protocol parameters, advanced applications, and actionable troubleshooting tips that leverage high-purity Gly-Gly-Phe-Gly from APExBIO for next-generation peptide engineering.

• HyperScript™ Reverse Transcriptase: Precision cDNA Synthesis

  2026-06-08

  HyperScript™ Reverse Transcriptase from APExBIO elevates cDNA synthesis workflows, excelling where structured or low-abundance RNA challenge conventional enzymes. Its advanced thermal stability and reduced RNase H activity drive superior results in high-demand applications such as qPCR and transcriptomic profiling.

• Silymarin: Milk Thistle Extract for Advanced Bench Research

  2026-06-07

  Silymarin, a milk thistle extract, offers unparalleled versatility for oxidative stress, cancer, and antiviral research, thanks to its well-characterized chemistry and robust protocol flexibility. This guide translates cutting-edge findings and expert workflow tips into actionable protocols, with troubleshooting strategies designed for reproducibility and reliable results.

16404 records 1/1094 page Next 12345 下5页 Last page